...
首页> 外文期刊>Journal of Oral and Maxillofacial Surgery >Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system.
【24h】

Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system.

机译:离体产生在无血清培养系统中生长的人结膜和口腔粘膜等效物。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We sought to develop full-thickness ex vivo produced human conjunctiva and oral mucosa equivalents using a serum-free culture system without a feeder layer and to compare conjunctiva and oral mucosa equivalents to assess their suitability as graft materials for eyelid reconstruction. MATERIALS AND METHODS: Human conjunctival and oral mucosal keratinocytes were cultured, expanded, and seeded onto AlloDerm (LifeCell Corp, Branchburg, NJ), a cadaveric, acellular dermis, to produce ex vivo produced full-thickness mucosa equivalents. Histology of equivalents and their expression of immunoreactive Ki-67, a proliferation marker, and GLUT1, a membrane antigen seen in barrier tissues, were examined at 4, 11, and 18 days after seeding onto AlloDerm. RESULTS: Progressive epithelial stratification was observed on day 4, 11, and 18 conjunctiva and oral mucosa equivalents. Ki-67 immunoreactivity progressively increased with cultured time in both types of equivalent, indicating the continued presence of actively proliferating cells. GLUT1 immunoreactivity, concentrated in the basal keratinocytes of stratified epithelia of both types of equivalents, mimicked native tissue and indicated a high glycolytic state of the basal cells. CONCLUSIONS: Conjunctival and oral mucosal equivalents are similar to native tissue and demonstrate high proliferative and glycolytic states. Due to the similarity to conjunctiva, oral mucosal equivalents may be useful for eyelid reconstruction. Their advantages for surgical reconstruction include 1) ease of obtaining autogenous oral epithelium for expansion in vitro without the possibility of contaminating cellular- or serum-borne biologic agents, 2) growth of intact, confluent epithelia on rigid, transplantable human allogeneic dermis that may be surgically transplanted, and 3) reduced donor site morbidity and surgical time.
机译:目的:我们试图使用无饲养层的无血清培养系统开发全厚度离体生产的人结膜和口腔粘膜等效物,并比较结膜和口腔粘膜等效物以评估其是否适合作为眼睑重建的移植材料。材料与方法:将人结膜和口腔粘膜角质形成细胞进行培养,扩增,然后播种到尸体,无细胞真皮AlloDerm(LifeCell Corp,Branchburg,NJ)上,以生产离体产生的全层粘膜等效物。在接种到异源真皮上后第4、11和18天,检查了等效物的组织学及其免疫反应性Ki-67(一种增殖标志物)和GLUT1(一种在屏障组织中看到的膜抗原)的表达。结果:在结膜和口腔粘膜当量的第4、11和18天观察到进行性上皮分层。在两种等同物中,Ki-67免疫反应性均随培养时间的增加而逐渐增加,表明持续存在活跃增殖的细胞。 GLUT1免疫反应性集中在两种类型的等价物的分层上皮细胞的基底角质形成细胞中,模仿了天然组织,并表明基底细胞处于高糖酵解状态。结论:结膜和口腔粘膜等效物与天然组织相似,并表现出高增殖和糖酵解状态。由于与结膜相似,因此口腔粘膜等效物可用于眼睑重建。它们在外科手术重建中的优势包括:1)易于获得自体口腔上皮以进行体外扩增,而不会污染细胞或血清载生物制剂; 2)完整,融合的上皮在刚性,可移植的人同种异体真皮上生长,可能是以及3)减少供体部位的发病率和手术时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号